Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAC TAVI 2: ticagrelor versus aspirin single antiplatelet therapy after TAVI
2021-003927-13Phase 4Active
- Sponsor
- Fundación Biomédica Galicia Sur
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in aortic stenosis (AS) comparing Ticagrelor SAPT with Aspirin SAPT (2 arms). Primary endpoint: Incidence of NACE. Started Oct 2021; status: active.
02
Drugs
ticagreloraspirin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2021-003927-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003927-13.